Xvivo Perfusion AB

26
Strong Sell
  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: SE0004840718
SEK
226.00
7.4 (3.39%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Million
Consolidated - Profit And Loss Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
No of Months
12
12
12
12
12
12
Operating Income
812.00
822.00
597.00
415.00
258.00
179.00
Less :Inter divisional transfers
0.00
0.00
0.00
0.00
0.00
0.00
Less: Excise
0.00
0.00
0.00
0.00
0.00
0.00
Net Sales
812.00
822.00
597.00
415.00
258.00
179.00
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
Raw Materials Consumed
0.00
0.00
0.00
0.00
0.00
0.00
Power & Fuel Cost
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
278.00
245.00
166.00
122.00
103.00
Operating Expenses
44.00
5.00
1.00
1.00
0.00
0.00
General and Administration Expenses
339.00
322.00
249.00
200.00
130.00
82.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Cost of Software developments
0.00
0.00
0.00
0.00
0.00
0.00
Miscellaneous Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Expenses Capitalised
0.00
0.00
0.00
0.00
0.00
0.00
Total Expenditure
719.00
706.00
559.00
396.00
262.00
193.00
Operating Profit (PBDIT) excl Other Income
93.00
115.00
38.00
18.00
-4.00
-13.00
Other Income
-2.00
117.00
95.00
19.00
30.00
-30.00
Operating Profit (PBDIT)
161.00
300.00
165.00
53.00
58.00
-30.00
Interest
44.00
5.00
1.00
1.00
0.00
0.00
Profit before Depriciation and Tax
0.00
0.00
0.00
0.00
0.00
0.00
Depreciation
70.00
67.00
30.00
15.00
32.00
13.00
Profit Before Taxation & Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
Exceptional Income / Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Profit Before Tax
38.00
199.00
94.00
22.00
6.00
-57.00
Provision for Tax
13.00
27.00
2.00
3.00
-1.00
-13.00
Profit After Tax
25.00
172.00
91.00
18.00
8.00
-43.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
Adj to Profit After Tax
0.00
0.00
0.00
0.00
0.00
0.00
Profit Balance B/F
0.00
0.00
0.00
0.00
0.00
0.00
Profit Available for appropriations
0.00
0.00
0.00
0.00
0.00
0.00
Appropriations
0.00
0.00
0.00
0.00
0.00
0.00
Equity Dividend (%)
Earnings Per Share
0.80
5.44
3.07
0.62
0.28
-1.61
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2025 is -1.25% vs 37.63% in Dec 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2025 is -19.53% vs 200.20% in Dec 2024

stock-summary

Interest

YoY Growth in year ended Dec 2025 is 692.14% vs 370.67% in Dec 2024

stock-summary

Profit After Tax

YoY Growth in year ended Dec 2025 is -85.39% vs 87.52% in Dec 2024

Compare Profit and Loss Results of Xvivo Perfusion AB
Markets Mojo
Figures in Million
consolidated - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(SEK)
Change(%)
No of Months
12
12
Operating Income
812.00
2,056.00
-1,244.00
-60.51%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
812.00
2,056.00
-1,244.00
-60.51%
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
0.00
0.00
0%
Raw Materials Consumed
0.00
0.00
0.00
0%
Power & Fuel Cost
0.00
0.00
0.00
0%
Employee Cost
0.00
803.00
-803.00
-100.00%
Operating Expenses
44.00
43.00
1.00
2.33%
General and Administration Expenses
339.00
664.00
-325.00
-48.95%
Selling and Distribution Expenses
0.00
0.00
0.00
0%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
0.00
0.00
0.00
0%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
719.00
1,704.00
-985.00
-57.81%
Operating Profit (PBDIT) excl Other Income
93.00
352.00
-259.00
-73.58%
Other Income
-2.00
120.00
-122.00
-101.67%
Operating Profit (PBDIT)
161.00
657.00
-496.00
-75.49%
Interest
44.00
43.00
1.00
2.33%
Profit before Depriciation and Tax
0.00
0.00
0.00
0%
Depreciation
70.00
185.00
-115.00
-62.16%
Profit Before Taxation & Exceptional Items
0.00
0.00
0.00
0%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
38.00
328.00
-290.00
-88.41%
Provision for Tax
13.00
44.00
-31.00
-70.45%
Profit After Tax
25.00
284.00
-259.00
-91.20%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
0.00
0.00
0.00
0%
Profit Available for appropriations
0.00
0.00
0.00
0%
Appropriations
0.00
0.00
0.00
0%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
0.7974
3.5456
-2.75
-77.51%
Profit And Loss - Net Sales
Net Sales 812.16 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is -1.25% vs 37.63% in Dec 2024

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 93.02 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is -19.53% vs 200.20% in Dec 2024

Profit And Loss - Interest
Interest 44.37 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 692.14% vs 370.67% in Dec 2024

Profit And Loss - Profit After Tax
Profit After Tax 25.16 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is -85.39% vs 87.52% in Dec 2024